LONG PULSE 1064 NM ND: YAG LASER IN THE TREATMENT OF ERYTHEMATOTELANGIECTATIC ROSACEA AND OTHER ERYTHEMATOTELAN-GIECTATIC FACIAL CONDITIONS

Shaveen Anwer Mustafa; Dindar Sharif Qurtas

doi:10.46903/gjms/23.4.1934

LONG PULSE 1064 NM ND: YAG LASER IN THE TREATMENT OF ERYTHEMATOTELANGIECTATIC ROSACEA AND OTHER ERYTHEMATOTELAN-GIECTATIC FACIAL CONDITIONS

Shaveen Anwer Mustafa, Dindar Sharif Qurtas

Abstract

Background: Rosacea is a long-term inflammatory skin disorder that mainly affects middle-aged people. This study set out to assess how effective and well-tolerated a long-pulse 1064 nm neodymium-doped yttrium aluminium garnet (Nd:YAG) laser is for treating erythematotelangiectatic rosacea and similar facial redness conditions.

Materials & Methods: A prospective interventional study was carried out with 32 patients, each receiving 3–4 treatment sessions spaced two weeks apart. The laser settings used included a 5 mm spot size, fluence of 4.07 J/cm², energy of 800 mJ, and frequency of 5 Hz. Redness levels were evaluated using the Clinician’s Erythema Assessment (CEA) and Patient Self-Assessment (PSA) scales, while visible blood vessels were measured using a new Telangiectasia Area Involvement Score (TAIS).

Results: Two weeks after the final session, the average CEA scores dropped significantly from 3.00 to 0.69 (p < 0.05), and PSA scores improved from 3.47 to 1.16 (p < 0.05). There was also a moderate improvement in telangiectasia. Side effects were mild and temporary, mainly short-term redness and slight itching.

Conclusion: Overall, the results suggest that long-pulse Nd:YAG laser treatment is both safe and effective in reducing facial redness in patients with erythematotelangiectatic rosacea.

Keywords

Erythematotelangiectatic Rosacea, Nd:YAG laser, Erythema, Telangiectasia

Full Text:

PDF

References

Zhang H, Tang K, Wang Y, Fang R, Sun Q. Rosacea Treatment: Review and Update. Dermatol Ther. 2021;11(1):13-24. https://doi.org/10.1007/s13555-020-00461-0

Chen A, Choi J, Balazic E, Zhu TR, Kobets K. Review of laser and energy-based devices to treat rosacea in skin of color. J Cosmet Laser Ther. 2024;26(1-4):43-53. https://doi.org/10.1080/14764172.2024.2376701

Choi YJ, Kim JY, Nam JH, Lee GY, Kim WS. Clinical outcome of 1064-nm picosecond neodymium–doped yttrium aluminium garnet laser for the treatment of hypertrophic scars. J Cosmet Laser Ther. 2019;21(2):91-8. https://doi.org/10.1080/14764172.2018.1469768

Li Y, Wang R. Efficacy comparison of pulsed dye laser vs. microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser in the treatment of rosacea: a meta-analysis. Front Med. 2022;8:798294. https://doi.org/10.3389/fmed.2021.798294

Salem SAM, Abdel Fattah NS, Tantawy SM, El-Badawy NM, Abd El-Aziz YA. Neodymium-yttrium aluminum garnet laser versus pulsed dye laser in erythemato-telangiectatic rosacea: comparison of clinical efficacy and effect on cutaneous substance (P) expression. J Cosmet Dermatol. 2013;12(3):187-94. https://doi.org/10.1111/jocd.12048

Kwon WJ, Park BW, Cho EB, Park EJ, Kim KH, Kim KJ. Comparison of efficacy between long-pulsed Nd:YAG laser and pulsed dye laser to treat rosacea-associated nasal telangiectasia. J Cosmet Laser Ther. 2018;20(5):260-4. https://doi.org/10.1080/14764172.2017.1418510

Maden S. Rosacea: An overview of its etiological factors, pathogenesis, classification and therapy options. Dermato. 2023;3(4):241-62. https://doi.org/10.3390/dermato3040019

Coleman W, Mariwalla K, Grimes P. Updating the Fitzpatrick classification: the skin color and ethnicity scale. Dermatol Surg. 2023;49(8):725-31. https://doi.org/10.1097/dss.0000000000003860

Soares I, Amaral IP, Correia MP, Travassos R, Filipe P. Complications of dermatologic lasers in high Fitzpatrick phototypes and management: an updated narrative review. Lasers Med Sci. 2024;39(1):149. https://doi.org/10.1007/s10103-024-04100-4

Ho SGY, Chan HHL. The Asian dermatologic patient. Am J Clin Dermatol. 2009;10(3):153-68. https://doi.org/10.2165/00128071-200910030-00002

Nobeyama Y. Rosacea in East Asian populations: clinical manifestations and pathophysiological perspectives for accurate diagnosis. J Dermatol. 2024;51(9):1143-56. https://doi.org/10.1111/1346-8138.17411

Sharma A, Kroumpouzos G, Kassir M, Galadari H, Goren A, Grabbe S, et al. Rosacea management: a comprehensive review. J Cosmet Dermatol. 2022;21(5):1895-904. https://doi.org/10.1111/jocd.14816

Seago M, Shumaker PR, Spring LK, Alam M, Al-Niaimi F, Anderson RR, et al. Laser treatment of traumatic scars and contractures: 2020 international consensus recommendations. Lasers Surg Med. 2020;52(2):96-116. https://doi.org/10.1002/lsm.23201

Kadhem AA, Al Saad AM, Toama AS. Rejuvenation of facial skin using fractional Er:YAG laser. Iraqi J Laser. 2020;19(1):53-61. https://doi.org/10.31900/ijl.v19i1.240

Asiran Serdar Z, Fisek Izci N. The evaluation of long-pulsed Nd:YAG laser efficacy and side effects in the treatment of cutaneous vessels on the face and legs. J Cosmet Dermatol. 2020;19(7):1656-61. https://doi.org/10.1111/jocd.13208

Tan J, Liu H, Leyden JJ, Leoni MJ. Reliability of clinician erythema assessment grading scale. J Am Acad Dermatol. 2014;71(4):760-3. https://doi.org/10.1016/j.jaad.2014.05.044

Tan J, Leoni M. Erythema of rosacea: validation of patient’s self-assessment grading scale. J Drugs Dermatol. 2015;14(8):841-4. PMID:26267728.

DOI: https://doi.org/10.46903/gjms/23.4.1934